Todd Haim, PhD, serves as senior advisor on biomedical innovation at the National Institute on Aging (NIA) and directs the NIA Office of Strategic Extramural Programs. He oversees approximately $150 million in annual seed funding that supports startups advancing cutting-edge technologies in aging, including AI-driven tools, digital health solutions, and next-generation biomedical innovations. Dr. Haim leads a team dedicated to strengthening NIA’s training, career development, and small business programs, expanding resources that help innovators translate scientific discoveries into real-world impact.

Before joining NIA, Dr. Haim served as program director at the National Cancer Institute’s SBIR Development Center and held roles at the National Academy of Sciences and Pfizer. He earned his PhD in biomedical research from the Albert Einstein College of Medicine and a technology commercialization certificate from the Johns Hopkins Carey Business School. Dr. Haim’s work has been recognized nationally through multiple awards, including the 2024 Champion of Small Business Commercialization Award and several NIH Director’s Awards.

‍